Amundi’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
39,573
+14,119
+55% +$327K ﹤0.01% 1359
2026
Q1
$524K Buy
25,454
+16,617
+188% +$375K ﹤0.01% 1533
2025
Q4
$210K Buy
+8,837
New +$215K ﹤0.01% 1751
2025
Q2
Sell
-172
Closed -$3.83K 2058
2025
Q1
$3.83K Buy
172
+55
+47% +$1.28K ﹤0.01% 1928
2024
Q4
$2.45K Buy
+117
New +$2.32K ﹤0.01% 1980

Other funds holding PRVA

Amundi's PRVA Position: Q2 2026 in Review

Amundi increased its Privia Health (PRVA) stake by 55% in Q2 2026, buying an estimated $327K and bringing the position to 39,573 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Amundi first reported a position in PRVA in Q4 2024 and has held it in 5 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Amundi held 39,573 shares of Privia Health worth $1.02M as of Q2 2026.
  • Amundi bought 14,119 Privia Health shares in Q2 2026, an estimated $327K.
  • Privia Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1359 holding.
  • Amundi first reported a position in Privia Health in Q4 2024 and has held it in 5 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.